検索結果 - 岡山大学学術成果リポジトリ

Effects of insulin-like growth factor-1 on the mRNA expression of estradiol receptors, steroidogenic enzymes, and steroid production in bovine follicles

フルテキストURL	fulltext.pdf
著者	Rawan, Ahmad Farid\| Langar, Hikmatullah\| Munetomo, Maho\| Yamamoto, Yuki\| Kawano, Kohei\| Kimura, Koji\|
キーワード	Estradiol receptor Follicle Insulin-like growth factor-1 (IGF-1) Steroidogenic enzymes
発行日	2023
出版物タイトル	Journal of Reproduction and Development
巻	69巻
号	6号
出版者	Society for Reproduction and Development
開始ページ	337
終了ページ	346
ISSN	0916-8818
NCID	AA10936678
資料タイプ	学術雑誌論文
言語	英語
OAI-PMH Set	岡山大学
著作権者	© 2023 by the Society for Reproduction and Development
論文のバージョン	publisher
PubMed ID	37940556
DOI	10.1262/jrd.2023-047
Web of Science KeyUT	001123890700005
関連URL	isVersionOf https://doi.org/10.1262/jrd.2023-047

Childcare and Child Development in Japan

JaLCDOI	10.18926/AMO/65970
フルテキストURL	77_5_479.pdf
著者	Murata, Akiko\| Matsumoto, Naomi\| Miyaji, Chikara\| Takao, Soshi\| Yorifuji, Takashi\|
抄録	For decades, the notion has persisted in developed countries that exclusive care by the mothers is best for the development of children up to 3 years of age. To examine the veracity of this “myth of the first three years” in Japan, we examined the effects of childcare facility use for children younger than 3 years on their development using the cohorts of the Longitudinal Survey of Newborns in the 21st Century conducted in Japan. Of the 47,015 respondents to the survey, we studied the children of 5,508 mothers with university/professional education to evaluate the relationships between primary early (< 2.5 years) childcare providers during weekday daytime hours and specific development indices for the ages of 2.5, 5.5, and 8 years. At the age of 2.5 and 5.5 years, children attending childcare facilities were judged as having more advanced developmental behaviors by their parents, such as being able to compose a two-word sentence (adjusted odds ratio [aOR]: 0.22) or to express emotions (aOR: 0.81), compared with those cared for by mothers. However, at the age of 8 years, children who attended childcare facilities as infants < 2.5 years showed more aggressive behavior in interrupting people (aOR: 1.20) and causing disturbances in public (aOR: 1.26) than those cared for by mothers (after adjustment for numerous child and parental factors). Although these results are generally consistent with previous studies, issues potentially involved with problem behavior such as quality of childcare require further investigation, as does the case of children of mothers with more modest educational attainment.
キーワード	“myth of the first three years” childcare child development problem behavior educational attainment
Amo Type	Original Article
出版物タイトル	Acta Medica Okayama
発行日	2023-10
巻	77巻
号	5号
出版者	Okayama University Medical School
開始ページ	479
終了ページ	490
ISSN	0386-300X
NCID	AA00508441
資料タイプ	学術雑誌論文
言語	英語
著作権者	Copyright Ⓒ 2023 by Okayama University Medical School
論文のバージョン	publisher
査読	有り
PubMed ID	37899259
Web of Science KeyUT	001108661600005

The Effectiveness of Pre-Operative Screening Tests in Determining Viral Infections in Patients Undergoing Oral and Maxillofacial Surgery

フルテキストURL	fulltext.pdf
著者	Sukegawa, Shintaro\| Sukegawa, Yuka\| Hasegawa, Kazuaki\| Ono, Sawako\| Nakamura, Tomoya\| Fujimura, Ai\| Fujisawa, Ayaka\| Nakano, Keisuke\| Takabatake, Kiyofumi\| Kawai, Hotaka\| Mukainaka, Yumika\| Nagatsuka, Hitoshi\| Furuki, Yoshihiko\|
キーワード	hepatitis B hepatitis C human immunodeficiency virus pre-operative examination
発行日	2022-07-20
出版物タイトル	Healthcare
巻	10巻
号	7号
出版者	MDPI
開始ページ	1348
ISSN	2227-9032
資料タイプ	学術雑誌論文
言語	英語
OAI-PMH Set	岡山大学
著作権者	© 2022 by the authors.
論文のバージョン	publisher
PubMed ID	35885875
DOI	10.3390/healthcare10071348
Web of Science KeyUT	000832459200001
関連URL	isVersionOf https://doi.org/10.3390/healthcare10071348

Effective highlighting modes of graphical user interfaces in visual information search

フルテキストURL	fulltext20210721-3.pdf
著者	Doi, Toshihisa\|
備考	This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: http://dx.doi.org/10.1007/s10209-021-00827-x\|
発行日	2021-7-8
出版物タイトル	Universal Access in the Information Society
巻	22巻
号	1号
出版者	Springer Science and Business Media LLC
開始ページ	111
終了ページ	119
ISSN	1615-5289
資料タイプ	学術雑誌論文
言語	英語
OAI-PMH Set	岡山大学
論文のバージョン	author
DOI	10.1007/s10209-021-00827-x
Web of Science KeyUT	000670833700001
関連URL	isVersionOf https://doi.org/10.1007/s10209-021-00827-x

Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment

フルテキストURL	fulltext.pdf
著者	Lin, Wenfeng\| Li, Chaoming\| Xu, Naijin\| Watanabe, Masami\| Xue, Ruizhi\| Xu, Abai\| Araki, Motoo\| Sun, Ruifen\| Liu, Chunxiao\| Nasu, Yasutomo\| Huang, Peng\|
キーワード	prostate cancer PLGA indocyanine green resiquimod photothermal therapy immunotherapy
発行日	2021-04-12
出版物タイトル	International Journal of Nanomedicine
巻	16巻
出版者	Dove Medical Press Ltd.
開始ページ	2775
終了ページ	2787
ISSN	1178-2013
資料タイプ	学術雑誌論文
言語	英語
OAI-PMH Set	岡山大学
著作権者	© 2021 Lin et al.
論文のバージョン	publisher
PubMed ID	33880023
NAID	120007034434
DOI	10.2147/IJN.S301552
Web of Science KeyUT	000639251200001
関連URL	isVersionOf https://doi.org/10.2147/IJN.S301552

Preoperative surgical risk stratification in osteosarcoma based on the proximity to the major vessels

フルテキストURL	Bone_Joint_J_101B_8.pdf
著者	Fujiwara, T.\| Medellin, M. R.\| Sambri , A.\| Tsuda, Y.\| Balko, J.\| Sumathi, V.\| Gregory, J.\| Jeys, L.\| Abudu, A.\|
発行日	2019-07-31
出版物タイトル	Bone and Joint Journal
巻	101-B巻
号	8号
出版者	British Editorial Society of Bone and Joint Surgery
開始ページ	1024
終了ページ	1031
ISSN	2049-4394
NCID	AA12602094
資料タイプ	学術雑誌論文
言語	英語
OAI-PMH Set	岡山大学
論文のバージョン	author
PubMed ID	31362545
DOI	10.1302/0301-620X.101B8.BJJ-2018-0963.R1
Web of Science KeyUT	000477976500019
関連URL	isVersionOf https://doi.org/10.1302/0301-620X.101B8.BJJ-2018-0963.R1

Outcomes of endoscopic treatment for malignant biliary obstruction in patients with surgically altered anatomy: analysis of risk factors for clinical failure

フルテキストURL	fulltext.pdf table.pdf
著者	Tomoda, Takeshi\| Kato, Hironari\| Miyamoto, Kazuya\| Matsumi, Akihiro\| Ueta, Eijiro\| Fujii, Yuuki\| Saragai, Yousuke\| Yamazaki, Tatsuhiro\| chida, Daisuke\| atsumoto, Kazuyuki\| Horiguchi, Shigeru\| Tsutsumi, Koichiro\| Okada, Hiroyuki\|
キーワード	Malignant biliary obstruction Double-balloon enteroscope Endoscopic retrograde cholangiopancreatography Surgically altered anatomy
備考	This fulltext is aailable in Jan. 2021.\|
発行日	2020-01-16
出版物タイトル	Surgical Endoscopy
ISSN	09302794
NCID	AA10750363
資料タイプ	学術雑誌論文
言語	英語
OAI-PMH Set	岡山大学
論文のバージョン	author
PubMed ID	31950273
DOI	10.1007/s00464-020-07385-y
Web of Science KeyUT	000507705600001
関連URL	isVersionOf https://doi.org/10.1007/s00464-020-07385-y

Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation

JaLCDOI	10.18926/AMO/56457
フルテキストURL	73_1_43.pdf
著者	Ikeda, Ailee\| Takaki, Akinobu\| Yasunaka, Tetsuya\| Oyama, Atsushi\| Adachi, Takuya\| Wada, Nozomu\| Onishi, Hideki\| Ikeda, Fusao\| Shiraha, Hidenori\| Yoshida, Kazuhiro\| Kuise, Takashi\| Nobuoka, Daisuke\| Yoshida, Ryuichi\| Umeda, Yuzo\| Yagi, Takahito\| Fujiwara, Toshiyoshi\| Okada, Hiroyuki\|
抄録	Post-orthotopic liver transplantation (OLT) hepatitis B recurrence is well-controlled with a nucleos(t)ide analogue and hepatitis B immunoglobulin (HBIG) combination, but the high cost and the potential risk of unknown infection associated with HBIG remain unresolved issues. Low-cost recombinant hepatitis B virus (HBV) vaccine administration is a potential solution to these problems. We retrospectively analyzed the rate and predictive factors of HBV vaccine success in 49 post-OLT patients: liver cirrhosis-type B (LC-B), n=28 patients; acute liver failure-type B (ALF-B), n=8; and non-HBV-related end-stage liver disease (non-B ESLD) who received a liver from anti-hepatitis B core antibody-positive donors, n=13. A positive anti-hepatitis B surface antibody response was achieved in 29% (8/28) of the LC-B group, 88% (7/8) of the ALF-B group, and 44% (4/9) of the adult non-B ESLD group. All four non-B ESLD infants showed vaccine success. The predictive factors for a good response in LC-B were young age, marital donor, and high donor age. ALF-B and non-B ESLD infants are thus good vaccination candidates. LC-B patients with marital donors are also good candidates, perhaps because the donated liver maintains an efficient immune memory to HBV, as the donors had already been infected in adulthood and showed adequate anti-HBV immune responses.
キーワード	acute liver failure hepatitis B hepatitis B vaccine liver cirrhosis liver transplantation
Amo Type	Original Article
出版物タイトル	Acta Medica Okayama
発行日	2019-02
巻	73巻
号	1号
出版者	Okayama University Medical School
開始ページ	41
終了ページ	50
ISSN	0386-300X
NCID	AA00508441
資料タイプ	学術雑誌論文
言語	英語
著作権者	CopyrightⒸ 2019 by Okayama University Medical School
論文のバージョン	publisher
査読	有り
PubMed ID	30820053
レファレンス	Ishigami M, Ogura Y, Hirooka Y and Goto H: Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation. World J Gastroenterol (2015) 21: 10290-10298.\| Kennedy M and Alexopoulos SP: Hepatitis B virus infection and liver transplantation. Curr Opin Organ Transplant (2010) 15: 310-315.\| Takaki A, Yagi T, Iwasaki Y, Sadamori H, Matsukawa H, Matsuda H, Shinoura S, Umeda Y, Miyake Y, Terada R, Kobashi H, Sakaguchi K, Tanaka N and Shiratori Y: Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation. Transplantation (2007) 83: 231-233.\| Takaki A, Yagi T and Yamamoto K: Safe and cost-effective control of post-transplantation recurrence of hepatitis B. Hepatol Res (2015) 45: 38-47.\| Holmberg SD, Suryaprasad A and Ward W: Updated CDC recommendations for the management of hepatitis B virus-infected health-care providers and students. MMWR Recomm Rep (2012) 61: 1-12.\| Rosenau J, Hooman N, Hadem J, Rifai K, Bahr MJ, Philipp G, Tillmann HL, Klempnauer J, Strassburg CP and Manns MP: Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation. Liver Transpl (2007) 13: 367-373.\| Yang A, Guo Z, Ren Q, Wu L, Ma Y, Hu A, Wang D, Ye H, Zhu X, Ju W and He X: Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study. PLoS One (2017) 12: e0188190.\| Egawa H, Tanabe K, Fukushima N, Date H, Sugitani A and Haga H: Current status of organ transplantation in Japan. Am J Transplant (2012) 12: 523-530.\| Takaki A, Yagi T, Yasunaka T, Sadamori H, Shinoura S, Umeda Y, Yoshida R, Sato D, Nobuoka D, Utsumi M, Yasuda Y, Nakayama E, Miyake Y, Ikeda F, Shiraha H, Nouso K, Fujiwara T and Yamamoto K: Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation? J Gastroenterol (2013) 48: 1373-1383.\| Mochida S: Indication criteria for liver transplantation for acute liver failure in Japan. Hepatol Res (2008) 38 Suppl 1: S52-55.\| Furukawa H, Shimamura T, Suzuki T, Taniguchi M, Nakanishi K, Yamashita K, Kamiyama T, Matsushita M and Todo S: Liver transplantation for hepatocellular carcinoma: the Japanese experience. J Hepatobiliary Pancreat Sci (2010) 17: 533-538.\| Kasahara M, Sakamoto S, Horikawa R, Koji U, Mizuta K, Shinkai M, Takahito Y, Taguchi T, Inomata Y, Uemoto S, Tatsuo K and Kato S: Living donor liver transplantation for pediatric patients with metabolic disorders: the Japanese multicenter registry. Pediatr Transplant (2014) 18: 6-15.\| Manini MA, Whitehouse G, Bruce M, Passerini M, Lim TY, Carey I, Considine A, Lampertico P, Suddle A, Heaton N, Heneghan M and Agarwal K: Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal. Dig Liver Dis (2018) 50: 944-953.\| Schumann A, Lindemann M, Valentin-Gamazo C, Lu M, Elmaagacli A, Dahmen U, Knop D, Broelsch CE, Grosse-Wilde H, Roggendorf M and Fiedler M: Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients. Transplantation (2009) 87: 103-111.\| Hu X, Ma S, Huang X, Jiang X, Zhu X, Gao H, Xu M, Sun J, Abbott WG and Hou J: Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease. J Viral Hepat (2011) 18: 458-467.\| Li Y, Tang L and Hou J: Role of interleukin-21 in HBV infection: friend or foe? Cell Mol Immunol (2015) 12: 303-308.\| Soejima Y, Ikegami T, Taketomi A, Yoshizumi T, Uchiyama H, Harada N, Yamashita Y and Maehara Y: Hepatitis B vaccination after living donor liver transplantation. Liver Int (2007) 27: 977–982.\| Chang SH, Suh KS, Yi NJ, Choi SH, Lee HJ, Seo JK and Lee KU: Active immunization against de novo hepatitis B virus infection in pediatric patients after liver transplantation. Hepatology (2003) 37: 1329-1334.\| Kwon CH, Suh KS, Yi NJ, Chang SH, Cho YB, Cho JY, Lee HJ, Seo JK and Lee KU: Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation. Pediatr Transplant (2006) 10: 479-486.\| Lee S, Kim JM, Choi GS, Park JB, Kwon CH, Choe YH, Joh JW and Lee SK: De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers. Liver Transpl (2016) 22: 247-251.\| Lin CC, Chen CL, Concejero A, Wang CC, Wang SH, Liu YW, Yang CH, Yong CC, Lin TS, Jawan B, Cheng YF and Eng HL: Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients. Am J Transplant (2007) 7: 195-200.\| Yoshizawa A, Yamashiki N, Ueda Y, Kaido T, Okajima H, Marusawa H, Chiba T and Uemoto S: Long-term efficacy of hepatitis B vaccination as post-transplant prophylaxis in hepatitis B surface antigen (HBsAg) positive recipients and HBsAg negative recipients of anti-hepatitis B core positive grafts. Hepatol Res (2016) 46: 541-551.\| Ota MO, Vekemans J, Schlegel-Haueter SE, Fielding K, Whittle H, Lambert PH, McAdam KP, Siegrist CA and Marchant A: Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults. Vaccine (2004) 22: 511-519.\| Tuaillon E, Tabaa YA, Petitjean G, Huguet MF, Pajeaux G, Fondere JM, Ponseille B, Ducos J, Blanc P and Vendrell JP: Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBVimmunized subjects by ELISPOT assay. J Immunol Methods (2006) 315: 144-152.\| Bauer T, Gunther M, Bienzle U, Neuhaus R and Jilg W: Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells. Liver Transpl (2007) 13: 434-442.\| Rosenau J, Hooman N, Rifai K, Solga T, Tillmann HL, Grzegowski E, Nashan B, Klempnauer J, Strassburg CP, Wedemeyer H and Manns MP: Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response. Transpl Int (2006) 19: 828-833.\| Di Paolo D, Lenci I, Cerocchi C, Tariciotti L, Monaco A, Brega A, Lotti L, Tisone G and Angelico M: One-year vaccination against hepatitis B virus with a MPL-vaccine in liver transplant patients for HBV-related cirrhosis. Transpl Int (2010) 23: 1105-1112.\| Sintusek P, Posuwan N, Wanawongsawad P, Jitraruch S, Poovorawan Y and Chongsrisawat V: High prevalence of hepatitis B-antibody loss and a case report of de novo hepatitis B virus infection in a child after living-donor liver transplantation. World J Gastroenterol (2018) 24: 752-762.\|

SUMS OF TWO BIQUADRATES AND ELLIPTIC CURVES OF RANK ≥ 4

著者	Izadi, F.A.\| Khoshnam, F.\| Nabardi, K.\|
発行日	2014-01
出版物タイトル	Mathematical Journal of Okayama University
巻	56巻
号	1号
資料タイプ	学術雑誌論文
JaLCDOI	10.18926/mjou/52068

数の多様な見方を育てる授業づくり第1学年「6, 7, 8, 9, 10の合成・分解」を通して

著者	深井文雄\|
発行日	1997-06-14
出版物タイトル	岡山大学算数・数学教育学会誌 : パピルス
巻	4巻
資料タイプ	紀要論文

Thermospermine suppresses auxin-inducible xylem differentiation in Arabidopsis thaliana

著者	Yoshimoto, Kaori\| Noutoshi, Yoshiteru\| Hayashi, Ken-ichiro\| Shirasu, Ken\| Takahashi, Taku\| Motose, Hiroyasu\|
発行日	2012-08
出版物タイトル	Plant Signaling & Behavior
巻	7巻
号	8号
資料タイプ	学術雑誌論文

下顎運動ニ伴フ眼瞼ノ異常運動

著者	大森操\|
発行日	1925-04-30
出版物タイトル	岡山医学会雑誌
巻	37巻
号	423号
資料タイプ	学術雑誌論文

「レントゲン」線ノ胎兒ニ及ボス影響　其4 海猽胎兒ニ就キテノ研究

著者	小坂成信\|
発行日	1928-10-31
出版物タイトル	岡山医学会雑誌
巻	40巻
号	10号
資料タイプ	学術雑誌論文

膵臟ラ氏島ノ組織學的研究及ビ其分泌機轉ニ就テ（第1報）

著者	大森三彦\|
発行日	1930-04-30
出版物タイトル	岡山医学会雑誌
巻	42巻
号	4号
資料タイプ	学術雑誌論文

心臟原基ノ發生ニ就キテ其ノ1 （鳥類殊ニ家鳩ニ於ケル檢索）

著者	吉田豐太\|
発行日	1931-11-30
出版物タイトル	岡山医学会雑誌
巻	43巻
号	11号
資料タイプ	学術雑誌論文

人胎兒睾丸ノ形態的竝ニ組織的研究

著者	森岡雄太郎\|
発行日	1937-01-31
出版物タイトル	岡山医学会雑誌
巻	49巻
号	1号
資料タイプ	学術雑誌論文

實驗的家兎及ビ海猽過敏症ニ於ケル血壓竝ニ呼吸ニ就テ

著者	徳重一志\|
発行日	1938-02-28
出版物タイトル	岡山医学会雑誌
巻	50巻
号	2号
資料タイプ	学術雑誌論文

過敏症抗體變動ニ關スル研究（第2報）「ベンツオール」ト抗體量トニ就テ

著者	横山丈夫\|
発行日	1939-08-31
出版物タイトル	岡山医学会雑誌
巻	51巻
号	8号
資料タイプ	学術雑誌論文

能働性免疫動物ニ及ボス受働性抗體ノ影響ニ關スル實驗的研究（第3編）能働性免疫動物ニ注入セシ溶血素ノ免疫經過ニ及ボス影響ニ就テ

著者	實成不二郎\|
発行日	1943-02-28
出版物タイトル	岡山医学会雑誌
巻	55巻
号	2号
資料タイプ	学術雑誌論文

犬肝臓の細胞内顆粒からのin vitro Histamine遊離に関する研究

著者	秦泉寺圭\|
発行日	1959-09-10
出版物タイトル	岡山医学会雑誌
巻	71巻
号	9-2号
資料タイプ	学術雑誌論文